Nanox Imaging Ltd. (NASDAQ: NNOX), a company focused on advancing preventive healthcare through its integrated medical imaging platform, announced that it will release its financial results for the second quarter ended June 30, 2026, before market open on September 9, 2026. The announcement underscores the company's commitment to transparency and its ongoing efforts to expand access to diagnostic imaging.
The company's CEO and Acting Chairman, Erez Meltzer, along with CFO Guy Nathanzon, will host a conference call at 8:30 a.m. ET to discuss the results and provide a business update. A live webcast will also be available through the Investor Relations section of the Nanox website, ensuring stakeholders can follow the proceedings in real time. This update comes at a pivotal moment as Nanox continues to build out its end-to-end medical imaging and healthcare services platform.
Nanox's strategy centers on making medical imaging more affordable and accessible, both within and beyond traditional hospital settings. The company's proprietary digital X-ray technology, combined with AI-driven analytics, aims to enhance routine imaging workflows, support early disease detection, and improve patient outcomes. The Nanox ecosystem includes several key components: Nanox.ARC, a cost-effective 3D multi-source digital tomosynthesis system; Nanox.AI, a suite of algorithms that augment CT imaging interpretation; Nanox.CLOUD, a secure cloud platform for data management and analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide remote radiology and cardiology services; and Nanox Health IT, offering RIS, PACS, AI, dictation, and secure infrastructure solutions.
The upcoming financial results will offer investors and industry observers a clearer picture of the company's operational and financial performance during the second quarter. Analysts will be closely watching for updates on the commercialization of Nanox.ARC, adoption of its AI solutions, and progress in building out its marketplace and teleradiology services. The business update may also shed light on the company's path to profitability and its cash runway, which are critical for a growth-stage medical technology firm.
Nanox's vision to lower barriers to adoption and improve utilization of imaging technology is particularly relevant in the context of global healthcare challenges. By integrating imaging hardware, AI, cloud infrastructure, and clinical expertise, Nanox seeks to enable earlier detection of chronic diseases, potentially reducing long-term healthcare costs and improving quality of life. The company's focus on preventive health aligns with broader industry trends toward value-based care and proactive health management.
Investors and enthusiasts can access the full press release for additional details at https://ibn.fm/y877D. For ongoing updates and news related to Nanox, the company's newsroom is available at http://ibn.fm/NNOX. The conference call and webcast will provide an opportunity for stakeholders to hear directly from management about the company's achievements and strategic direction. As Nanox continues to evolve its platform, the second-quarter results will be a key indicator of its progress in transforming the medical imaging landscape.
